Skip to content

QuidelOrtho Corporation QDEL Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture

Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.22M+122,200%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture?
QuidelOrtho Corporation (QDEL) reported shares issued, value, share-based payment arrangement, after forfeiture of $1.8M in Q1 2026.
How has QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture changed year-over-year?
QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture decreased by 40.0% year-over-year, from $3M to $1.8M.
What is the long-term trend for QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's shares issued, value, share-based payment arrangement, after forfeiture has grown at a -28.8% compound annual growth rate (CAGR), from $13.6M to $6.9M.
What does shares issued, value, share-based payment arrangement, after forfeiture mean?
Reflects the total value of equity instruments issued to employees and directors as part of compensation arrangements, net of forfeitures. This metric highlights the extent to which the company utilizes stock-based incentives to align employee interests with shareholders. It is a key component in evaluating dilution and total compensation strategy.